Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation (Q43682605)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2001
edit
Language Label Description Also known as
English
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
scientific article published in January 2001

    Statements

    Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation (English)
    M Boeckh
    R A Bowden
    B Storer
    N J Chao
    R Spielberger
    D K Tierney
    G Gallez-Hawkins
    T Cunningham
    K G Blume
    D Levitt
    J A Zaia
    1 January 2001
    343-351

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit